Advanced Cell Diagnostics

Company Website

ACD shortens the path to personalized medicine by unlocking the power of RNA biomarkers. Advanced Cell Diagnostics, Inc. (ACD) is a leader in the emerging field of molecular pathology, developing cell- and tissue-based diagnostic tests for personalized medicine. Based in the heart of Silicon Valley, ACD was founded and managed by experienced entrepreneurs in the life science industry. ACD’s products and services are based on its proprietary RNAscope® Technology, the first multiplex fluorescent and chromogenic in situ hybridization platform capable of detecting and quantifying RNA biomark.... Read more

Independent of your genes of interest, our easy RNA  in situ  hybridization assay us...

The RNAscope ® Multiplex Fluorescent assays are ideal for simultaneous detection st...

For labs that require high throughput and automated RNA in situ hybridization (ISH...

The BaseScope™ Assay is a unique product from ACD, based on the same platform ...

The RNAscope ®  and BaseScope™ Assays are based on the proprietary RNAscope ®  Techn...

ACD shortens the path to personalized medicine by unlocking the power of RNA biomarkers.

Advanced Cell Diagnostics, Inc. (ACD) is a leader in the emerging field of molecular pathology, developing cell- and tissue-based diagnostic tests for personalized medicine. Based in the heart of Silicon Valley, ACD was founded and managed by experienced entrepreneurs in the life science industry.

ACD’s products and services are based on its proprietary RNAscope® Technology, the first multiplex fluorescent and chromogenic in situ hybridization platform capable of detecting and quantifying RNA biomarkers in situ at single molecule sensitivity.

In addition to its ongoing efforts to develop proprietary diagnostic tests for cancer management, ACD also establishes partnerships with pharmaceutical and biotechnology companies to validate biomarkers for targeted therapeutic development. These internal and external efforts will continue to position ACD as a leader in molecular diagnostics and companion diagnostics.

The company’s technology overcomes critical hurdles in the identification and validation of biomarkers for companion diagnostics. ACD’s RNAscope® platform provides a new way of localizing and measuring RNA in situ with exceptional levels of sensitivity, specificity, and the ability to multiplex. Turnaround time for a new assay is reduced to three weeks. These advantages make the technology a powerful tool to address the issue of patient and disease heterogeneity, thus shortening the path to personalized medicine.

Browse All Advanced Cell Diagnostics Products (see all)

Browse Products by Field

Contact Advanced Cell Diagnostics

3960 Point Eden Way
Hayward CA 94545
USA
510-259-9847
Company Website